Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Covalon Technologies ( (TSE:COV) ) has shared an update.
Covalon Technologies plans to hold its annual meeting of shareholders on March 25, 2026, at 2:00 p.m. Eastern Time in a virtual-only format accessible via live webcast. The event will feature a presentation by CEO Brent Ashton followed by a question-and-answer session, providing shareholders with direct insight into the company’s strategic direction.
Registered and non-registered shareholders will be able to participate online, with specific procedures in place for voting and appointing proxyholders through TSX Trust’s virtual meeting platform. The company has also made its management information circular, financial statements, and MD&A available through regulatory and corporate channels, underscoring its focus on transparency and shareholder engagement ahead of the meeting.
The most recent analyst rating on (TSE:COV) stock is a Buy with a C$2.00 price target. To see the full list of analyst forecasts on Covalon Technologies stock, see the TSE:COV Stock Forecast page.
Spark’s Take on COV Stock
According to Spark, TipRanks’ AI Analyst, COV is a Neutral.
The score is primarily supported by improved profitability versus 2022–2023 and strong TTM cash generation alongside low leverage. It is held back by the recent TTM margin and revenue step-down and a high P/E (~51), while technicals are mixed (shorter-term strength but still below the 200-day trend with slightly negative MACD).
To see Spark’s full report on COV stock, click here.
More about Covalon Technologies
Covalon Technologies Ltd. is a Canadian MedTech company that develops advanced wound care, vascular access, and surgical consumable products aimed at improving healing, reducing healthcare-associated infections, and protecting skin integrity. Its solutions are designed for patients and care providers, and the company is listed on the TSX Venture Exchange under COV and trades on the OTCQX Market under CVALF.
Average Trading Volume: 15,662
Technical Sentiment Signal: Sell
Current Market Cap: C$49.44M
Find detailed analytics on COV stock on TipRanks’ Stock Analysis page.